Missteps in "tango" for epigenome targeting

Keith D Robertson, Kapil N. Bhalla

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.

Original languageEnglish (US)
Pages (from-to)2569-2570
Number of pages2
JournalBlood
Volume114
Issue number13
DOIs
StatePublished - 2009
Externally publishedYes

Fingerprint

Azacitidine
Histone Deacetylase Inhibitors
Leukemia
Blood
Therapeutics
entinostat

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Missteps in "tango" for epigenome targeting. / Robertson, Keith D; Bhalla, Kapil N.

In: Blood, Vol. 114, No. 13, 2009, p. 2569-2570.

Research output: Contribution to journalArticle

Robertson, Keith D ; Bhalla, Kapil N. / Missteps in "tango" for epigenome targeting. In: Blood. 2009 ; Vol. 114, No. 13. pp. 2569-2570.
@article{149a85f444894210919307ce5abe6250,
title = "Missteps in {"}tango{"} for epigenome targeting",
abstract = "In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.",
author = "Robertson, {Keith D} and Bhalla, {Kapil N.}",
year = "2009",
doi = "10.1182/blood-2009-07-231662",
language = "English (US)",
volume = "114",
pages = "2569--2570",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "13",

}

TY - JOUR

T1 - Missteps in "tango" for epigenome targeting

AU - Robertson, Keith D

AU - Bhalla, Kapil N.

PY - 2009

Y1 - 2009

N2 - In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.

AB - In this issue of Blood, Fandy and colleagues describe the results of a trial in which leukemia patients were treated with 5-azacytidine (5-azaC) and the HDAC inhibitor, entinostat. 1 Their results confirm the therapeutic efficacy of these agents but also demonstrate that we have much to learn about the mechanism of action of agents that target the epigenome.

UR - http://www.scopus.com/inward/record.url?scp=70449480361&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70449480361&partnerID=8YFLogxK

U2 - 10.1182/blood-2009-07-231662

DO - 10.1182/blood-2009-07-231662

M3 - Article

C2 - 19779044

AN - SCOPUS:70449480361

VL - 114

SP - 2569

EP - 2570

JO - Blood

JF - Blood

SN - 0006-4971

IS - 13

ER -